Money · Federal contracts

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

$76,775,310 in contract dollars, fiscal year 2026Confirmed from the official record
Unique Entity ID (UEI)
CNPVCR8DK7M8
Parent company
EMERGENT BIOSOLUTIONS INC (UEI DKEFA8JAW3X4)
Registered address
GAITHERSBURG, MD, district MD-06
Other names on record
EMERGENT IMMUNOSOLUTIONS INC/BIOPORT CORP; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INCORPORATED

Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.

Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 19, 2026.

The largest vendors

Which agencies pay this vendor, and where the work is done

Fiscal year 2027

USAspending lists no contract dollars for this vendor in fiscal year 2027 yet.

Fiscal year 2026: $76,775,310

Contract dollars by awarding agency, Fiscal year 2026
AgencyContract dollars
Department of Health and Human Services$76,775,310
Contract dollars by House district, Fiscal year 2026
District where the work is doneContract dollars
MD-06April McClain Delaney$76,764,078
MD-08Jamie Raskin$11,232

Largest awards

The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.

Largest contract awards, by each award's total over its life
AwardAgencyWhere the work is doneAward totalStart
HHSO100201600030CIGF::OT::IGFDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseGAITHERSBURG, MD-06$1,409,725,727.10Ends September 29, 2026
75A50119C00071ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseGAITHERSBURG, MD-06$857,637,641.46Ends September 30, 2026
75A50123C00037MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKINDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseGAITHERSBURG, MD-06$118,563,679Ends July 29, 2033
75N98026P00379HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC.Department of Health and Human ServicesNational Institutes of HealthROCKVILLE, MD-08$11,232Ends March 31, 2027

Subcontracts it reported

A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.

No subcontract is reported under this vendor’s largest awards.

Lobbying reports and campaign receipts that name this vendor

A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.

Lobbying reports that name EMERGENT BIOSOLUTIONS INC

How it matched: parent company name, exact name: the name in the lobbying report as client.

Lobbying reports
RegistrantClientAmount for the whole quarterQuarterFiledReport
THE NICKLES GROUP, LLCEMERGENT BIOSOLUTIONS$25,000reported as incomeThird quarter of 2026Open the report
CGCN GROUP, LLCEMERGENT BIOSOLUTIONS INC.$60,000reported as incomeThird quarter of 2026Open the report
EMERGENT BIOSOLUTIONS INC.EMERGENT BIOSOLUTIONS INC$450,000reported as expensesThird quarter of 2026Open the report
Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote